Filters

C2CD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

C2CD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) size: 1.0 µg DNA 3535

Supplier ABM LENTIVECTORS
Price 3535
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetC2CD3 Lentiviral Vector (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Short nameC2CD3 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Green Fluorescent-2A-Puro), C2CD3 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 24564
Gene C2CD3
Long gene name C2 calcium dependent domain containing 3
Synonyms DKFZP586P0123
Locus 11q13, 4
Discovery year 2007-10-17
GenBank acession BC035599
Entrez gene record 26005
RefSeq identity NM_015531
Classification C2 domain containing
Havana BLAST/BLAT OTTHUMG00000168110

Similar products

Subscribe to our Newsletter